Peri‐prostatic adipose tissue: the metabolic microenvironment of prostate cancer ZD Nassar, AT Aref, D Miladinovic, CY Mah, GV Raj, AJ Hoy, LM Butler BJU international 121, 9-21, 2018 | 66 | 2018 |
The inverse relationship between prostate specific antigen (PSA) and obesity AT Aref, AD Vincent, ME O’Callaghan, SA Martin, PD Sutherland, AJ Hoy, ... Endocrine-related cancer 25 (11), 933-941, 2018 | 28 | 2018 |
The first BGICC consensus and recommendations for breast cancer awareness, early detection and risk reduction in low‐and middle‐income countries and the MENA region H Elghazaly, AT Aref, BO Anderson, B Arun, CH Yip, H Abdelaziz, ... International journal of cancer 149 (3), 505-513, 2021 | 13 | 2021 |
Breast-gynaecological & immuno-oncology international cancer conference (BGICC) consensus and recommendations for the management of triple-negative breast cancer H Elghazaly, HS Rugo, HA Azim, SM Swain, B Arun, M Aapro, EA Perez, ... Cancers 13 (9), 2262, 2021 | 11 | 2021 |
Transforming growth factor-β1 gene expression in hepatocellular carcinoma: a preliminary report IM Farid, IM Hamza, DM El-Abd, AM Mohyi, MMA AbdulLatif, AT Aref, ... Arab Journal of Gastroenterology 15 (3-4), 142-147, 2014 | 10 | 2014 |
Do we need regional guidelines for breast cancer management in the MENA region? MENA Breast Cancer Guidelines project R Fayed, D Hamza, H Abdallah, M Kelany, A Tahseen, AT Aref ecancermedicalscience 11, 2017 | 6 | 2017 |
Targeting brain cancer R Reddel, A Aref Science 377 (6605), 467-468, 2022 | 3 | 2022 |
Pan-cancer diagnostic proteomic signature of tissue-of-origin (TOO) using data-independent acquisition mass spectrometry (DIA-MS) from 1289 human tissue samples. E Boys, J Liu, Z Cai, Z Noor, KL Mackenzie, A Aref, E Sykes, D Xavier, ... Journal of Clinical Oncology 41 (16_suppl), 3120-3120, 2023 | 2 | 2023 |
Transformer-based deep learning integrates multi-omic data with cancer pathways Z Cai, RC Poulos, A Aref, PJ Robinson, RR Reddel, Q Zhong bioRxiv, 2022.10. 27.514141, 2022 | 1 | 2022 |
Proteomic-based stratification of intermediate-risk prostate cancer patients Q Zhong, R Sun, AT Aref, Z Noor, A Anees, Y Zhu, N Lucas, RC Poulos, ... Life Science Alliance 7 (2), 2024 | | 2024 |
A 19-protein signature to predict outcomes in a cohort of stage II and III CRC. R Habib, A Aref, A Anees, M Pathan, D McLeod, RL Balleine, ... Journal of Clinical Oncology 41 (16_suppl), 3129-3129, 2023 | | 2023 |
A proteomic-based prognostic signature of pancreatic adenocarcinoma AT Aref, AKM Azad, A Anees, M Pathan, J Grealey, DL Smith, ... Cancer Research 83 (7_Supplement), 2209-2209, 2023 | | 2023 |
Machine learning of cancer type and tissue of origin from proteomes of 1,277 human tissue samples and 975 cancer cell lines Z Cai, Z Noor, AT Aref, EL Boys, D Xavier, N Lucas, SG Williams, JM Koh, ... Cancer Research 83 (7_Supplement), 5391-5391, 2023 | | 2023 |
A six-protein signature predicts response and survival in patients with advanced cutaneous melanoma treated with immunotherapy S Manda, AT Aref, EK Sykes, SG Williams, JM Koh, EM Humphries, ... Cancer Research 83 (7_Supplement), 5479-5479, 2023 | | 2023 |
Defining the role of lipids and metabolic factors as risk factors for prostate cancer incidence and aggressiveness AT Aref | | 2019 |
Highlights from 11th Breast-Gynecological and Immunooncology International Cancer Conference (BGICC), 17–18 January 2019, Egypt H El-Ghazaly, N Bahie-Eldin, A Aref ecancermedicalscience 13, 2019 | | 2019 |
Highlights from the 10th Breast, Gynaecological and Immunotherapy International Cancer Conference (BGICC), 18–19 January 2018, Cairo, Egypt H El-Ghazaly, A Aref, N Bahie-Eldin ecancermedicalscience 12, 2018 | | 2018 |
The inverse relationship between prostate specific antigen (PSA) and obesity in healthy men; support for a hormonal, rather than haemodilution mechanism AT Aref, A Vincent, M O'Callaghan, A Hoy, L Butler, G Wittert Wiley, 2017 | | 2017 |
Screening of Clinical Practice in Management of Progression on Trastuzumab in metastatic breast cancer A Aref, D Hamza, R Fayed J Cancer Prev Curr Res 5 (1), 00147, 2016 | | 2016 |
New Options for Treatment of Metastatic Sarcoma Pose a Challenge in Selecting the Best One A Aref | | 2014 |